| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.300 | None | 0.981 | 1 | 0 | 2008 | 2020 | ||||||||
|
nerve growth factor receptor | 0.477 | 0.846 | 9.8E-02 |
|
disease | 0.300 | None | 0.957 | 1 | 0 | 1989 | 2019 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.300 | None | 0.982 | 1 | 0 | 1989 | 2020 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.300 | None | 0.923 | 1 | 0 | 2000 | 2019 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
neuroglobin | 0.631 | 0.462 | 4.5E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
LDL receptor related protein 1 | 0.482 | 0.769 | 1.00 |
|
disease | 0.300 | None | 0.935 | 1 | 0 | 1996 | 2019 | ||||||||
|
synaptophysin | 0.481 | 0.808 | 0.92 |
|
disease | 0.300 | None | 0.970 | 1 | 0 | 1996 | 2019 | ||||||||
|
glyceraldehyde-3-phosphate dehydrogenase | 0.447 | 0.808 | 0.11 |
|
disease | 0.300 | None | 0.895 | 1 | 0 | 1994 | 2018 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 0.978 | 1 | 0 | 1999 | 2019 | ||||||||
|
nerve growth factor | 0.391 | 0.885 | 0.82 |
|
disease | 0.300 | None | 0.969 | 1 | 0 | 1989 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.300 | None | 0.972 | 1 | 0 | 1998 | 2019 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2000 | 2020 | ||||||||
|
choline O-acetyltransferase | 0.520 | 0.808 | 5.6E-11 |
|
disease | 0.300 | None | 0.981 | 1 | 0 | 1987 | 2019 | ||||||||
|
PPARG coactivator 1 alpha | 0.453 | 0.885 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
cyclin dependent kinase 5 | 0.495 | 0.846 | 0.14 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2000 | 2020 | ||||||||
|
insulin receptor substrate 1 | 0.488 | 0.769 | 2.4E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.938 | 1 | 0 | 1993 | 2019 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.520 | None | 1.000 | 5 | 0 | 1997 | 2018 | ||||||||
|
insulin | 0.445 | 0.923 | 0.30 |
|
disease | 0.530 | None | 1.000 | 1 | 0 | 1991 | 2020 | ||||||||
|
ATP synthase F1 subunit alpha | 0.604 | 0.731 | 1.00 |
|
disease | 0.540 | None | 1.000 | 1 | 0 | 2003 | 2017 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
disease | 0.560 | None | 1.000 | 2 | 0 | 2005 | 2020 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.570 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.600 | None | 1.000 | 6 | 0 | 1996 | 2019 | ||||||||
|
insulin degrading enzyme | 0.604 | 0.577 | 6.6E-03 |
|
disease | 0.600 | None | 0.955 | 4 | 0 | 2000 | 2019 |